Skip to main content
Figure 2 | BMC Pulmonary Medicine

Figure 2

From: Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study

Figure 2

Relationship between indacaterol concentration and QTcF change from baseline following 14-day treatment with indacaterol. The solid diagonal line represents the estimated regression of concentration against change from baseline in QTcF interval; the dotted diagonal line represents the corresponding 95% upper confidence band. The horizontal lines show 0 and 10 ms change from baseline in QTcF interval; the vertical lines are the geometric mean and 90% confidence limits for Cmax in the indacaterol 600 μg group.

Back to article page